Posts

Hospital Ventilation Systems May Facilitate Increased V...

In recent years, especially following the onset of the COVID-19 pandemic, the re...

UT Health San Antonio School of Dentistry Researcher Se...

In an exciting development for oncology and biotechnology, a researcher from the...

Do Dogs Serve a Purpose? New Chapman Study Questions Br...

Since their domestication thousands of years ago, dogs have held the title of ma...

New Study Unveils the Protective Properties of Amniotic...

Researchers from Oregon Health & Science University (OHSU) have recently unveile...

Prescribed Burning: A Key Practice for Enhancing Biodiv...

As grasslands face increasing threats from urbanization and agricultural expansi...

Surprising Discovery: Ear Muscles Thought Dormant in Hu...

The auricular muscles, often deemed vestigial in humans, have long intrigued sci...

Emerging Evidence: Low-Level Air Pollution Associated w...

Long-term exposure to low-level traffic-related air pollution has recently been ...

Leveraging Generative AI to Target Previously Undruggab...

Biomedical engineers at Duke University have made significant strides in the fig...

Researchers Uncover Polar Bear Fur’s Ice-Repelling Secr...

Research conducted by an international team led by the University of Surrey has ...

Enhanced Vaccination and Surveillance Urged Following P...

Between September and December 2024, a notable public health concern emerged as ...

First Analysis of Sugar-Fed Healthy Gut Bacteria Unveiled

A recent groundbreaking study has unveiled the intricate workings of a beneficia...

Study Finds No Correlation Between Maternal Illness Dur...

Certain health conditions experienced by mothers during pregnancy have long been...

AZ, Daiichi’s Enhertu Bags 7th FDA Green Light, First F...

Enhertu, the first antibody-drug conjugate (ADC) developed by AstraZeneca and Da...

Versant introduces another obesity biotech with “clinic...

Versant Ventures established Helicore Biopharma exactly two months after establi...

Atalanta Therapeutics Secures $97 Million to Advance si...

Atalanta Therapeutics has raised $97 million in a successful Series B financing ...

Leap Therapeutics Shifts Focus to Colorectal Cancer Aft...

Leap Therapeutics has decided to redirect its efforts towards colorectal cancer ...